07/08/2025
8:07 AM | Crescent Biopharma (Subject)
CRESCENT BIOPHARMA, INC. (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
06/23/2025
5:48 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:51 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Moran Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:32 PM | Fairmount Funds Management LLC (Filed by)
Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form SCHEDULE 13D | |
06/23/2025
5:41 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Lubner David Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:43 PM | Balcom Alexandra (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:46 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:22 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Moran Susan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:23 PM | Balcom Alexandra (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:23 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Violin Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:24 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Lubner David Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for CBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Crescent Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
06/23/2025
5:25 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:26 PM | Brumm Joshua T (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:27 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
McNeill Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:28 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Scalzo Richard William (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:29 PM | Doughty Christopher Grant (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:29 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Lynch Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
3:30 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G | |
06/18/2025
4:28 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
5:53 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:30 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
7:30 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
7:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
05/29/2025
7:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
05/14/2025
11:15 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form EFFECT | |
05/14/2025
4:06 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
3:39 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 424B3 | |
05/12/2025
6:12 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form S-4/A | |
04/28/2025
7:00 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:01 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
04/28/2025
7:17 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form S-4/A | |
04/28/2025
7:00 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
04/04/2025
12:29 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form S-4/A | |
04/03/2025
6:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
04/03/2025
6:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
02/28/2025
4:05 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
02/27/2025
5:01 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
02/14/2025
5:38 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
8:00 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
8:00 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form DEFA14A | |
Missed the Run So Far? This Is Your Second Chance (Ad) According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made.
Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up. Join The Crypto Code Workshop + get $10 in Bitcoin for attending |
12/26/2024
3:30 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
1:22 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G | |
11/13/2024
3:30 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
3:42 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
3:47 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form DEFA14A | |
11/06/2024
4:41 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
11/04/2024
1:01 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Weinstein Benjamin (Filed by)
| Form SCHEDULE 13G/A | |
10/29/2024
7:09 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:09 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form DEFA14A | |
08/15/2024
4:01 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
08/09/2024
3:30 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:30 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
4:16 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
2:55 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
6:24 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
07/29/2024
4:55 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Siren, L.L.C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
